More

    Infographic: Abbott (ABT) reports Q2 2020 earnings

    Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell 8% to b $7.3 billion, while adjusted EPS declined 31% to $0.57.

    However, the results were stronger than street projections, which sent the stock up 1% during pre-market hours. The stock has gained 11% since the beginning of this year.  

    Abbott Laboratories Q2 2020 earnings infographic

    Looking forward to listening to management/ analysts comments on Q2 results? Stay tuned here for Abbott Q2 2020 earnings call transcript

    The largest Medical Devices unit was the worst hit, where sales dropped 21%, as hospitals postponed various surgeries to cater to COVID patients. Earlier today, rival Johnson & Johnson (NYSE: JNJ) also reported a massive 35% decline in quarterly earnings, hurt by weakness in the medical devices segment.

    Past performance

    Also read: Abbott (ABT) could make a new 52-week high after upbeat Q2 results and rosier outlook

    Related articles

    Comments

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO SEO